Ind-Swift Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve inter alia, to Consider and Approve Un-Audited Financial Results for the quarter and half year ended September 30, 2026.

Ref.: ISLL:CH:2026 Date: 15th October, 2026 BSE Limited, National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor, 25th Floor, Dalal Street, Plot No. C/2, G-Block, Mumbai 400001 Bandra Kurla Complex, Bandra (E), Mumbai 400051 BSE Scrip Code: 532305 NSE Symbol: INDSWFTLAB Sub: Notice of Board meeting Pursuant to Regulation 29 of the SEBI (LODR), Regulations, 2015 Respected Sir/Ma’am, Pursuant to the provisions of Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015 (“SEBI Listing Regulations”) notice is hereby given that meeting of the Board of Directors of Ind-Swift Laboratories Ltd. is scheduled to be held on Thursday, October 29, 2026, inter-alia to consider, approve and take on record the Standalone and Consolidated Un-Audited Financial Results of the Company for the quarter and half year ended 30th September, 2026. Please note that the information regarding closure of Trading Window for dealing in the securities of the Company is already provided to the Stock Exchanges, where the shares of the Company are listed, vide our letter dated September 28, 2026. Further, the above information is also available on the Company’s website at www.indswiftgroup.com under the head Investors. You are requested to kindly take the same on record. With Regards, For IND-SWIFT LABORATORIES LTD. PARDEEP VERMA VP-CORPORATE AFFAIRS & COMPANY SECRETARY